Light Mode
$70.11 ↑ +0.00 (+0.00%) Trading Up from the previous close of $70.11, $5.68 below the day’s high of $75.79
+47.68 (+212.57%) / 6M
Momentum, market sentiment, and recent alerts
TXG reads not so good: price sits above one of the two key moving averages, the 12-month move is +411.8%.
No alerts for TXG in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.